• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Cetuximab Extends Survival In Advanced Non-Small Cell Lung Cancer

0
  • by alexperjescuadmin
  • in News
  • — 16 Mar, 2008
Cetuximab Extends Survival In Advanced Non-Small Cell Lung Cancer
AudioMedica News
Cetuximab Extends Survival In Advanced Non-Small Cell Lung Cancer
Cetuximab Extends Survival In Advanced Non-Small Cell Lung Cancer
00:00 /
RSS Feed
Share
Link
Embed
Robert Pirker
Robert Pirker

ROBERT PIRKER , Medical University of Vienna
Phase III study results have detected improvements in overall survival among patients with advanced non-small cell lung cancer treated with a monoclonal antibody targeted to the epidermal growth factor receptor: EGFR. Robert Pirker told the Turin congress he thinks is an emerging role for EGRF-targeted antibodies in lung cancer for patients who test positive for the epidermal growth factor receptor. He discussed the data with Peter Goodwin.



LISTEN

[audio:https://www.audiomedica.com/podcasting/oncology/080316_robert_pirker.mp3]

Share

Tags: cancercetuximabimprovementslungmedicationmonoclonalpatientreceptorstudysurvivaltest

You may also like...

  • Quitting smoking cuts risk of cataract Meta-analysis finds dietary fibre protective against heart disease 24 Jan, 2014
  • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen. Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease. 7 Mar, 2014
  • Mathias Rummel Indolent Lymphoma Standard Therapy Needs To Change: Bendamustine-Rituximab: Better Than CHOP-Rituximab 7 Jun, 2012
  • AACR In New Partnership For San Antonio Breast Cancer Symposium AACR In New Partnership For San Antonio Breast Cancer Symposium 14 Dec, 2007

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Lung Cancer Screening: Wait for Prospective Study Findings!
  • Next story Bevacizumab: New Standard for Non-Small Cell Lung Cancer?
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Microbiome Diversity Key To Survival After…
    • Head and Neck Cancer Therapy De-Escalation: A…
    • Ibrutinib: New Frontline Standard for Chronic…
    • Handgrip Strength Predicts Survival in Elderly…
    • ALK—Targeted Lung Cancer Drugs Benefited Real…
  • Home
  • News
  • Cetuximab Extends Survival In Advanced Non-Small Cell Lung Cancer

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.